Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Docandu is an innovative digital health platform designed both for patients & doctors, making digital healthcare accessible from anywhere. Docandu aims to be a key tech health service provider, starting from Greece, improving the existing national and private health care services. The global digital health market is estimated to be worth $536 Billion by 2025. To date, they have developed two separate apps for doctors and patients. They have also received an angel investment of 100,000 Euros and sponsorship of $25,000 from Microsoft. The company has initiated early-stage relationships with a couple of Greek public and private health entities. With the proceeds, they will execute their go-to-market strategy and make global health ID a reality, by expanding its affiliate network of doctors, health providers and public health systems.
days to go:
Expired
investment:
£70,900
Symmetrical Power has developed an innovative solution that addresses the issue of energy wastage. After identifying the inefficiency of the 3 Phase Electrical Distribution Boards, Symmetrical Power is creating the ‘Intelligent Distribution Board’ (ID Board). It aims to prevent the challenge of peak demand whilst saving on energy bills. The working model of the product also received positive feedback from electrical specialists. Additionally, Symmetrical Power was also a Shell Springboard regional finalist (2018) for its new low-carbon ideas. With the proceeds, the company will complete design & begin distribution in Europe and to position itself as the go-to Distribution Board provider.
days to go:
Expired
investment:
£233,600
Wellbeing Sisters (WS) is a company that offers wellbeing advice, hosts an online shop, and sells a subscription box full of toxin-free health, beauty, and nutritional products by and for women. The company first launched its subscription box in 2019 for women trying to conceive. WS witnessed a sell-out of its series of one-off boxes tailored towards conceiving, pregnancy, early motherhood, midlife and menopause in 2020. WS aims to be a contender in the UK subscription box market that is set to be worth £1 billion by 2022. The company asserts that it has organically grown its social media following consisting of over 5,000 supporters. It will use the investment to invest in technology, product development, and marketing/PR.
days to go:
Expired
investment:
£153,394
Alyve provides personalised subscription nutrition powered by Artificial Intelligence (AI). It argues that 8.2 million UK vitamin users are looking for personalised nutrition in one capsule. Alyve asserts that its product can fulfil this demand. Users complete a 3-minute questionnaire where their responses are recorded by Alyve's intelligent algorithms. These then, based on the responses, help the user select one of Alyve's nutritional pills best matched to their goals and needs. Alyve then delivers the pills to the user's doorstep every 30 days. The company has recorded 4000+ questionnaires and completed 800+ orders in 25 countries since Q4 of 2020. It aims to become a contender in the $21 billion supplement market. The company will use the investment received to increase marketing efforts, transform Alyve into a household brand, introduce new product lines, increase staff, improve technology, and transform both digital and physical User Experiences (UX).
days to go:
Expired
investment:
£227,782
Fightback is a beer and cider brand on a mission to save music venues with support from across the live music industry. The company claims that every pint sold contributes to Music Venue Trust (MVT), a UK-registered charity, which acts to protect, secure, and improve Grassroots Music Venues. It argues that it has sold 10,000 pints and 10,000 cans in 61 venues before the COVID-19 lockdown. Fightback asserts that it has agreed on a new national distribution deal to make the brand more accessible amidst the lockdown. It intends to supply 900+ venues affiliated with MVT when venues reopen. Fightback will use the investment to roll out beer and cider to help secure the long-term future of the venues that ensure that the music culture is kept alive.
days to go:
Expired
investment:
£52,596
Medics2You's is a hybrid telehealth platform that connects patients with healthcare experts around the globe with focus on Africa through a smart device from anywhere, six days a week. The company has a pilot project underway in Nigeria, a nation which spends $500m-1bn annually on outbound healthcare tourism. Medics2You aims to reach out to over 100m people unable to access quality healthcare. Medics2You's partnership with Lantum has given the company access to 18000+ doctors and 3000 clinicians. The funds will be used to create the web portal, expand the team, set up local centres, and enhance marketing activities.
days to go:
Expired
investment:
£156,370
